Programme

This programme is a draft version and is subject to changes.

Day 1 – 14 October 2010

 

09:30    Registration of ETPN Members

 

10:00     ETP Nanomedicine General Assembly

               (for ETPN members, discussion of ETPN internal issues)

            Chair - Bertrand Loubaton, Director, GE Healthcare

                        1) Welcome and introduction,

                            Bertrand Loubaton

                        2) Activity and Management Report of the Platform,

                            Sebastian Lange

                        3) Next Steps and Opportunities of the ETPN,

                            Mike Eaton

 

12:00    Lunch Break

 

13:00   Welcome Address

            Giampaolo Landi di Chiavenna, Health Department

            Municipality of Milan


            ETP Nanomedicine Forum - Opening: Europe’s Activities

            towards Nanomedicine,
            Rudolf Strohmeier, European Commission,

            Deputy Director-General DG RTD


            Strategic activities of the ETPN until 2015,
            Bertrand Loubaton, GE Healthcare, ETPN Chairman

 

            Nanomedicines: Consideration for success,

            safety, and service
            Philippe Martin, European Commission, DG SANCO


            Experiences of a grant-making foundation: liaison between

            R&D funding and technology transfer,
            Carlo Mango, Cariplo Foundation


            Technology transfer as a model to enlarge patients’ care

            perspectives: the Don Gnocchi Foundation experience,
            Furio Gramatica, Don Gnocchi Foundation


14:30    Industrial Keynote I

            Neil Desai, Abraxis Bioscience

 

15:00    Industrial Keynote II

            Roger Carline, eminate Limited

 

15:30    Coffee Break and Posters Exhibition


16:00    Regulatory Issues in Nanomedicine
            Chair - Joan Albert Vericat, AG Regulatory, Director Preclinical

            Development, Noscira SA


            EMEA activities related to Nanomedicine,
            Marisa Papaluca, Deputy Head of Sector European Medicines

            Agency


            Report on French “Support to Innovation” programme
            Dominique Masset, AFSSAPS


            Challenges in translational research for Nanomedicines:

            from bench to the clinic... and restart?

            Rogério Gaspar, Professor, Faculty of Pharmacy,

            University of Lisbon


            Round table discussion

            Moderation: Prof. Bärbel Dorbeck-Jung, University of Twente

 

17:15    Industrial Opportunities and Challenges in Nanomedicine
            Chair and introductory remarks - Hans Hofstraat, Philips Healthcare


            1) Birgit Nelsen-Salz, Lonza

            2) Evelyne Vuaridel, Debiopharm

            3) Laurent Levy, Nanobiotix

            4) Marc Ramis Castelltort, Endor Nanotechnologies

 

18:30    End of 1st day

 

19:30    High Level Evening Dinner

 

 

Day 2 – 15 October 2010

 

08:30    Open Presentation Session –
            Flash Presentations of project ideas and/or latest

            technological developments

            Chair - Furio Gramatica, Don Gnocchi Foundation


           

Part 1

 

  • Magnetic nanoworms and nanowires for Nanomedicine

           Prof. Yuri Gunko, Trinity College Dublin

  • Uppsala Berzelii Centre for Neurodiagnostics

           Dr. Fredrik Nikolajeff, Uppsala University

  • Results of preclinical studies of the drug for treatment of oncologic diseases on the basis of SP ³-nanoparties

          Dr. Nikolay Odintsov, NANO-S

  • Nanostructured Porous Silicon Particles in Targeted Drug Delevery Therapies

           Dr. Ester Pastor, EM Silicon Nanotechnologies

  • Multiparameter microsystem by nanosensors arrays integration on flexible substrates

           Dr. Dumitru Ulieru, SITEX 45 SRL

  • FP7 NMP.2011.1.2-2 New therapeutics using nanotechnology to transport macromolecules across biological barriers

           Lisa Hearty, Queen Mary University of London

 

Part 2

 

  • Nanoparticle-based RNAi therapeutics

           Dr. Kenneth Howard, Aarhus University

  • Lipid based MR nanoparticles for brain receptor binding

           Prof. Dr. Olaf Haraldseth, The Norwegian University of Science and

           Technology

  • NANDIATREAM - an integrated nanotech approach to cancer diagnostics

          Prof. Dr. Yuri Volkov, Trinity College Dublin

  • Microstructured Dry Electrodes for Biopotential Monitoring

          Dr. Elena Forvi, Don Gnocchi Foundation- Biomedical Technology Department

  • Nanoparticles for early detection of Arthritis

          Dr. Géraldine Coullerez, Ecole Polytechnique Fédérale de Lausanne

  • Single-molecule techniques for the discovery and monitoring of amyloid growth and interactive processes

          Dr. Daniele Gazzola, University of Bologna

 

 

09:40    Coffee Break and Posters Exhibition


10:00    Clinical Needs related to Nanomedicine
            Chair - Patrick Hunziker, University Basel, Clinam


            Nanomedicine - Barriers and pitfalls from bench to bedside

            Thomas Gottwald, Ovesco

          

            Exploring the inaccessible Health territories using micro-

            nanotechnologies: a strong clinical need

            François Berger, INSERM Grenoble


            Perspectives towards the development, targeting and use

            of siRNA

            Michael Derks, F. Hoffmann-La Roche

 

            Immunotoxicity and Immunogenicity of Nanodrugs

            Janos Szebeni, Bay Zoltan Foundation


            Immunostimulatory Nanoparticles for the Treatment of

            Allergic Asthma; Results of Placebo-controlled

            Phase II-Study

            Wolfgang Renner, Cytos Biotechnology

 

11:50    Business Concepts - Fundings
            Chair - Maaike van Velzen, Philips Intellectual Property & Standards


            EU funding in Nanomedicine,
            Heico Frima, European Commission, DG RTD


            European funding instrument in Nanomedicine:

            EuroNanoMed,
            Virginie Sivan, CEA & Coord. Era-Net Euronanomed

 

            Wellcome Trust: An Alternative Source of Finance for

            Translational R+D,
            Richard Seabrook, Wellcome Trust


13:00    Networking Lunch Break and Posters Exhibition

 

14:00    (Open-) Innovation in Nanomedicine

            Chair - Mike Eaton

 

             ETP Nanomedicine Opinion Paper,

             Mike Eaton

 

             Open-innovation strategy of Sanofi-Aventis
             Sabina Improta, Sanofi Aventis

 

             Example of a novel research infrastructure concept,

             Simo Schwartz Navarro, CIBER-BBN


15:15    Closing

            Bertrand Loubaton, ETP Nanomedicine


15:30    End of Annual Forum 2010

 

15:30    Mirror Group Meeting ETPN

            Chair - Bertrand Loubaton / Virginie Sivan    

  

            Meeting of the ETP Mirror group representatives of national public

            authorities, organised by the ETPN in cooperation with the ERA-Net

            Euronanomed

 

18:00    End of day 2nd day

 

 --------------------------------------------

 

Document Actions